Understanding the genetic basis for adverse drug effects: the calcineurin inhibitors.

Understanding the genetic basis for adverse drug effects: the calcineurin inhibitors.

Item
http://www.wikidata.org/entity/Q37680948
HNF4alpha dysfunction as a molecular rational for cyclosporine induced hypertensionCrystallization and preliminary crystallographic study of a trypsin-resistant catalytic domain of human calcineurin.Management of hypertension in renal transplant patients: a comprehensive review of nonpharmacologic and pharmacologic treatment strategies.Metabolic syndrome in patients with hematological diseases.Systems pharmacology modeling: an approach to improving drug safety.Central modulation of cyclosporine-induced hypertension.Predictive Modeling of Tacrolimus Dose Requirement Based on High-Throughput Genetic Screening.Update on the clinical pharmacogenomics of organ transplantation.The interactions of age, sex, body mass index, genetics, and steroid weight-based doses on tacrolimus dosing requirement after adult kidney transplantation.Posterior reversible encephalopathy syndrome in children with kidney disease.Association of Whole Blood Tacrolimus Concentrations with Kidney Injury in Heart Transplantation Patients.Age and gender may affect posterior reversible encephalopathy syndrome in renal disease.Identification of factors affecting tacrolimus level and 5-year clinical outcome in kidney transplant patients
P2860

Understanding the genetic basis for adverse drug effects: the calcineurin inhibitors.

Item
http://www.wikidata.org/entity/Q37680948
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Understanding the genetic basis for adverse drug effects: the calcineurin inhibitors.
@en
Understanding the genetic basis for adverse drug effects: the calcineurin inhibitors.
@nl
type
label
Understanding the genetic basis for adverse drug effects: the calcineurin inhibitors.
@en
Understanding the genetic basis for adverse drug effects: the calcineurin inhibitors.
@nl
prefLabel
Understanding the genetic basis for adverse drug effects: the calcineurin inhibitors.
@en
Understanding the genetic basis for adverse drug effects: the calcineurin inhibitors.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P356
P1433
P1476
Understanding the genetic basis for adverse drug effects: the calcineurin inhibitors.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698